AS combined with transthyretin cardiac amyloidosis has attracted attention in recent years, because their coexistence must always be taken into consideration since both transthyretin cardiac amyloidosis and severe AS result in LVH, thus interfering with the detection of suspected coexistence of transthyretin cardiac amyloidosis. The gene discussed is TTR; the disease is cardiac amyloidosis.